Clustering Deviation Index (CDI): a robust and accurate internal measure for evaluating scRNA-seq data clustering
Jiyuan Fang(Duke University), Jichun Xie(University of Minnesota), Diyuan Qin(Sichuan University), Qi-Jing Li(Agency for Science, Technology and Research), Cliburn Chan(Duke University), Liuyang Wang(Zhejiang Medicine (China)), Kouros Owzar(Duke University)
Cited by 17
Related Papers
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
|Journal of Clinical Oncology|2008|655